Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367722208> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W4367722208 endingPage "382" @default.
- W4367722208 startingPage "369" @default.
- W4367722208 abstract "Objective: Sublingual buprenorphine/naloxone (Bup/Nx) is approved for addiction treatment and may be useful for pain management, particularly in opioid-treated patients with pain with nonadherence behaviors. The transition of opioid-treated patients with pain to buprenorphine carries the risk of precipitated withdrawal and increased pain. This study convened pain and addiction specialists to develop and pilot a clinical protocol for safe transitioning to Bup/Nx. Design: The protocol was revised three times based on outside expert review and pilot study observations. The pilot was conducted with a prospective cohort of 12 patients with moderate to severe chronic pain, who were receiving long-term opioid therapy with any full µ-agonist drug, and had exhibited one or more aberrant drugrelated behaviors. Patients were followed up for 3-6 months with the expectation that they would experience few adverse events (AEs) and report lower pain severity. Results: The three patients on the highest baseline opioid dose (equivalent to 303-450 mg of oral morphine) and the three on the lowest doses (=20 mg) had early AEs when switched to Bup/Nx and did not complete the trial. Of the remaining six, one withdrew due to AEs; one responded well, then withdrew; and four completed a 3-month trial. A mixed-effects model controlling for dropouts found that average and worst pain significantly decreased after the switch to Bup/Nx (both p < 0.01). Conclusion: Based on this experience, the protocol recommends Bup/Nx for pain only when baseline opioid doses are within bounds that reduce AEs at transition and incorporates dose flexibility to further reduce risks. This protocol warrants further testing. Keywords: buprenorphine, chronic pain, treatment guidelines, opioid therapy, withdrawal DOI:10.5055/jom.2012.0137" @default.
- W4367722208 created "2023-05-04" @default.
- W4367722208 creator A5001270419 @default.
- W4367722208 creator A5001462488 @default.
- W4367722208 creator A5010070935 @default.
- W4367722208 creator A5017911936 @default.
- W4367722208 creator A5040831614 @default.
- W4367722208 creator A5048142898 @default.
- W4367722208 creator A5081922663 @default.
- W4367722208 creator A5084369652 @default.
- W4367722208 creator A5085548207 @default.
- W4367722208 creator A5090628353 @default.
- W4367722208 creator A5090665326 @default.
- W4367722208 date "2012-11-01" @default.
- W4367722208 modified "2023-10-14" @default.
- W4367722208 title "Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: Development and pilot test of a clinical protocol" @default.
- W4367722208 doi "https://doi.org/10.5055/14" @default.
- W4367722208 hasPublicationYear "2012" @default.
- W4367722208 type Work @default.
- W4367722208 citedByCount "0" @default.
- W4367722208 crossrefType "journal-article" @default.
- W4367722208 hasAuthorship W4367722208A5001270419 @default.
- W4367722208 hasAuthorship W4367722208A5001462488 @default.
- W4367722208 hasAuthorship W4367722208A5010070935 @default.
- W4367722208 hasAuthorship W4367722208A5017911936 @default.
- W4367722208 hasAuthorship W4367722208A5040831614 @default.
- W4367722208 hasAuthorship W4367722208A5048142898 @default.
- W4367722208 hasAuthorship W4367722208A5081922663 @default.
- W4367722208 hasAuthorship W4367722208A5084369652 @default.
- W4367722208 hasAuthorship W4367722208A5085548207 @default.
- W4367722208 hasAuthorship W4367722208A5090628353 @default.
- W4367722208 hasAuthorship W4367722208A5090665326 @default.
- W4367722208 hasConcept C118552586 @default.
- W4367722208 hasConcept C126322002 @default.
- W4367722208 hasConcept C168563851 @default.
- W4367722208 hasConcept C170493617 @default.
- W4367722208 hasConcept C1862650 @default.
- W4367722208 hasConcept C197934379 @default.
- W4367722208 hasConcept C2777389121 @default.
- W4367722208 hasConcept C2778750930 @default.
- W4367722208 hasConcept C2778949969 @default.
- W4367722208 hasConcept C2781063702 @default.
- W4367722208 hasConcept C2781118164 @default.
- W4367722208 hasConcept C2994577977 @default.
- W4367722208 hasConcept C42219234 @default.
- W4367722208 hasConcept C48856860 @default.
- W4367722208 hasConcept C535046627 @default.
- W4367722208 hasConcept C71924100 @default.
- W4367722208 hasConceptScore W4367722208C118552586 @default.
- W4367722208 hasConceptScore W4367722208C126322002 @default.
- W4367722208 hasConceptScore W4367722208C168563851 @default.
- W4367722208 hasConceptScore W4367722208C170493617 @default.
- W4367722208 hasConceptScore W4367722208C1862650 @default.
- W4367722208 hasConceptScore W4367722208C197934379 @default.
- W4367722208 hasConceptScore W4367722208C2777389121 @default.
- W4367722208 hasConceptScore W4367722208C2778750930 @default.
- W4367722208 hasConceptScore W4367722208C2778949969 @default.
- W4367722208 hasConceptScore W4367722208C2781063702 @default.
- W4367722208 hasConceptScore W4367722208C2781118164 @default.
- W4367722208 hasConceptScore W4367722208C2994577977 @default.
- W4367722208 hasConceptScore W4367722208C42219234 @default.
- W4367722208 hasConceptScore W4367722208C48856860 @default.
- W4367722208 hasConceptScore W4367722208C535046627 @default.
- W4367722208 hasConceptScore W4367722208C71924100 @default.
- W4367722208 hasIssue "6" @default.
- W4367722208 hasLocation W43677222081 @default.
- W4367722208 hasOpenAccess W4367722208 @default.
- W4367722208 hasPrimaryLocation W43677222081 @default.
- W4367722208 hasRelatedWork W2016893828 @default.
- W4367722208 hasRelatedWork W2319465159 @default.
- W4367722208 hasRelatedWork W2804415042 @default.
- W4367722208 hasRelatedWork W2898142040 @default.
- W4367722208 hasRelatedWork W3012256084 @default.
- W4367722208 hasRelatedWork W3037586716 @default.
- W4367722208 hasRelatedWork W3122497334 @default.
- W4367722208 hasRelatedWork W4234764147 @default.
- W4367722208 hasRelatedWork W4506089 @default.
- W4367722208 hasRelatedWork W62138238 @default.
- W4367722208 hasVolume "8" @default.
- W4367722208 isParatext "false" @default.
- W4367722208 isRetracted "false" @default.
- W4367722208 workType "article" @default.